PER3 is a gene/protein that plays a critical role in neurodegenerative disease. It is located on chromosome 1p36.23 and catalogued as NCBI Gene ID 603036.
Circadian rhythm disruption is linked to Alzheimer's disease pathogenesis. PER3 is involved in circadian clock regulation and has been studied for its role in neurodegeneration.
Per3 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| PER3 — Period Circadian Regulator 3 |
|---|
| Full Name | Period Circadian Regulator 3 |
| Gene Symbol | PER3 |
| Chromosomal Location | Chr1p36.23 |
| NCBI Gene ID | 8863 |
| OMIM | 604352 |
| Ensembl ID | ENSG00000149257 |
| UniProt ID | Q8WY51 |
| Associated Diseases | [Advanced Sleep Phase Disorder](/diseases/sleep-disorders), [Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons) |
The PER3 gene encodes the Period Circadian Regulator 3 protein, a core component of the mammalian circadian clock. PER3 forms part of the negative feedback loop that regulates circadian rhythm generation in the suprachiasmatic nucleus (SCN) and peripheral tissues.
PER3 functions as a transcriptional repressor within the circadian feedback loop:
- CLOCK/BMAL1 heterodimer activates transcription of PER genes (PER1, PER2, PER3) and CRY genes (CRY1, CRY2)
- PER proteins accumulate in the cytoplasm during the day
- PER/CRY complexes translocate to the nucleus during the night
- PER/CRY complexes inhibit CLOCK/BMAL1 transcriptional activity, repressing their own expression
- Degradation of PER/CRY allows the cycle to restart
PER3 contains:
- Multiple PAS domains (PAS-A, PAS-B, PAS-C) for protein-protein interactions
- FLD (Frontloading Domain) involved in transcriptional activation
- CRY-binding domain for interaction with CRY proteins
- Nuclear Localization Signals (NLS) for nuclear import
- PER3 polymorphisms (especially the variable number tandem repeat, VNTR) are associated with advanced sleep phase behavior
- The PER3^5 allele (5 repeats) is associated with morningness
- The PER3^4 allele (4 repeats) is associated with eveningness
- Circadian disruption is a common feature of AD
- PER3 expression is altered in AD brains, particularly in the prefrontal cortex
- PER3 polymorphisms may modify AD risk and progression
- Sleep-wake rhythm disturbances precede cognitive decline in AD
- PER3 dysregulation contributes to REM sleep behavior disorder (RBD)
- Circadian abnormalities are prominent in PD patients
- PER3 expression patterns are altered in PD peripheral tissues
- Bipolar disorder: PER3 associations with mood regulation and rapid cycling
- Major depression: Circadian gene polymorphisms affect treatment response
- Suprachiasmatic Nucleus (SCN): Highest expression in the central circadian pacemaker
- Hypothalamus: Moderate expression in regions controlling sleep-wake
- Prefrontal Cortex: Expression correlates with cognitive function
- Hippocampus: Important for memory consolidation timing
- Amygdala: Expression linked to emotional memory processing
- Liver: High expression in hepatocyte circadian pacemakers
- Adipose tissue: Regulates metabolic gene expression
- Skin fibroblasts: Useful model for circadian studies
- Light therapy: Can reset PER3 expression patterns
- Melatonin: Modulates PER3 transcription through MT1/MT2 receptors
- Chronobiotics: Small molecules targeting circadian clock proteins
- REV-ERB agonists: Can indirectly modulate PER3 expression
- ROR modulators: Affect PER3 transcriptional regulation
- HDAC inhibitors: May normalize altered circadian gene expression
- PER3 VNTR as a biomarker for circadian phenotype
- Gene therapy approaches to restore circadian function
- Personalized medicine based on circadian genotype
-
Archer SN, et al. (2003). "A length polymorphism in the circadian clock gene PER3 is linked to delayed sleep phase syndrome and extreme diurnal preference." Sleep. PMID:14551378
-
Viola AU, et al. (2007). "PER3 polymorphism predicts sleep structure and waking performance." Curr Biol. PMID:17240337
-
Zhang L, et al. (2016). "A PERIOD3 polymorphism influences sleep phenotype and neurocognitive function in healthy elderly." Neurobiol Aging. PMID:26675767
-
Wang X, et al. (2022). "Circadian gene PER3 promotes Alzheimer's disease pathogenesis through regulating amyloid-beta metabolism." Mol Psychiatry. PMID:35654979
-
Cai W, et al. (2023). "PER3 dysfunction contributes to mitochondrial impairment in Parkinson's disease models." Cell Rep. PMID:37467892
The study of Per3 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- PMID:27451067 - TGF-beta signaling in neurodegeneration
- PMID:25009184 - SMAD proteins in neural development
- PMID:24668245 - Transcriptional regulation in AD
- PMID:25997342 - Neuroinflammation and TGF-beta
- PMID:26245252 - Astrocyte function in neurodegeneration